At present, in the process of studying the treatment of breast cancer, some scholars have found that an estrogen receptor α subtype (estrogen receptor alpha, ERα) can be used as a key target for effective treatment of breast cancer, and compounds that can antagonize the activity of ERα can be used as candidate drugs for the treatment of breast cancer. Here, ESR1 is linked to breast cancer.